Animal models of tumor immunity, immunotherapy and cancer vaccines
- 1 April 2004
- journal article
- review article
- Published by Elsevier BV in Current Opinion in Immunology
- Vol. 16 (2), 143-150
- https://doi.org/10.1016/j.coi.2004.01.003
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- HER-2/neu-Specific Monoclonal Antibodies Collaborate with HER-2/neu-Targeted Granulocyte Macrophage Colony-Stimulating Factor Secreting Whole Cell Vaccination to Augment CD8+ T Cell Effector Function and Tumor-Free Survival in Her-2/neu-Transgenic MicePublished by The American Association of Immunologists ,2003
- Immunotherapy of spontaneous mammary carcinoma with fusions of dendritic cells and mucin 1-positive carcinoma cellsImmunology, 2003
- Prevention of Spontaneous Breast Carcinoma by Prophylactic Vaccination with Dendritic/Tumor Fusion CellsPublished by The American Association of Immunologists ,2003
- Low effectiveness of DNA vaccination against HER-2/neu in ageingVaccine, 2003
- MUC1-specific CTLs are non-functional within a pancreatic tumor microenvironmentGlycoconjugate Journal, 2001
- Mouse 4T1 Breast Tumor ModelCurrent Protocols in Immunology, 2000
- Mice with Spontaneous Pancreatic Cancer Naturally Develop MUC-1-Specific CTLs That Eradicate Tumors When Adoptively TransferredPublished by The American Association of Immunologists ,2000
- A novel orthotopic model of breast cancer metastasis to boneClinical & Experimental Metastasis, 1999
- Prostate cancer in a transgenic mouse.Proceedings of the National Academy of Sciences of the United States of America, 1995
- Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease.Molecular and Cellular Biology, 1992